Introduction
The epidemic today
The tobacco epidemic is expanding, and is likely to do so for several decades to come. This growth of death and disease comes despite centuries of knowledge and decades of action, progress in policy development and public awareness, multiple World Health Assembly resolutions, 15 World Conferences starting from 1967, many regional, national and sub-national meetings, regional action plans and more recently the World Health Organization Framework Convention on Tobacco Control (WHO FCTC), 1 which came into effect in 2005, the 2011 United Nations (UN) High Level Meeting Summit on noncommunicable diseases 2 and some serious funding. 3 Most of today's smokers are men-almost 800 million men smoke, with 80% living in low-and middle-income countries (LMIC). 4, 5 Nearly a third of all smokers in the world-.300 million-live in China alone. The epidemic started later in women, and currently there are 200 million female smokers, and the prevalence is higher in the high-income countries. 6 The prevalence of smoking among health professionals is still at unacceptably high levels-over 30% in many countries in Europe and Latin America. 7 
Health effects
Tobacco kills half of its users-half of the deaths in the middle age and half in the older age. In 2011 alone, it was estimated that tobacco killed almost 6 million people, with 80% of these deaths occurring in the LMIC, 6 and a further 600 000 individuals-mostly women and children-from second-hand smoke, 5 the latter being considered by some as a form of child abuse. The harmful effects of tobacco are well documented, but new risks continue to emerge. There is no safe way to use tobacco. Encouragingly, the harmful effects, including the risk of dying, diminish after quitting.
Economic costs of tobacco
Tobacco companies insist that tobacco is good for the economy, but they ignore the corresponding debit-the myriad substantial direct and indirect costs of tobacco-medical and healthcare costs, higher sickness and absence rates, loss of skilled workers by premature death and increased early retirement due to ill health, time off work for 'smoke breaks', lost production and lower productivity. There are additional costs in the risks of second-hand smoke, including the risk of an employer being sued for failing to provide a safe and healthy workplace, free from second-hand smoke. There are further costs from urban and rural fires caused by careless smoking, damage to building fabric and the litter of billions of cigarettes, matches, packets and lighters discarded every day. Added to this list are the costs of deforestation as trees are cut down to cure tobacco, the cost of the use of arable land that could grow food and the loss of foreign exchange if cigarettes are imported.
Implementing tobacco control
The medical model is not enough nor a new paradigm: if there is one lesson that has been learned in public health in the last 30 years it is that the traditional medical model is not enough to deal with the harm caused by tobacco (and the same applies for many of the other risk factors for the major non-communicable diseases, such as inactivity, poor diet and alcohol use). Tobacco control has led the way for health advocates to understand how this new paradigm can be used to control risk factors. Any reduction in the tobacco epidemic-in fact, in the whole non-communicable diseases epidemic-will not be achieved in the corridors of hospitals and clinics, but in the corridors of power, involving government, politics, tackling big business, crime and corruption, legislation, taxation, trade, media, litigation and the need to form unusual partnerships such as with customs officials, lawyers, women's groups, environmentalists and many more. It behoves the health professions to move into new fields and alliances to master this new paradigm. Yet few medical or health-related curricula in any training schools or universities teach political lobbying, how to present a case for increased tobacco taxation to a Minister of Finance, how to counter the nefarious arguments of the tobacco industry and how to debate the industry in the media.
The vector of the tobacco epidemic is the tobacco industry, and no campaigns to reduce tobacco can ignore the need to understand and counter this industry. The tobacco industry-whether it be the global corporations, national monopolies or their local components-remains highly profitable, expansive, adaptive and amoral, and is a formidable opponent of tobacco control. Naively believing it is possible to work with the industry is doomed, as the remit of the industry upon which its very existence depends and its responsibilities to its shareholders, is to sell more cigarettes. The remit of the health professions is to reduce consumption of cigarettes, which is a diametrically opposite corner of the ring.
Nor is tobacco use simply a matter of personal choice. Children start smoking because of the image ( perpetrated by the tobacco industry) of being cool, rebellious, adult, macho, slim, glamorous, healthy and attractive to the opposite gender. Children and adults continue to smoke because nicotine is addictive, encompassing the standard triad of physical, psychological and social addiction. It is thus no more ethical to blame a smoker than to blame a type 2 diabetic, or someone who contracts malaria, for their illness. And it is always the duty of the health profession to reduce disease, disability and death as best possible.
As pointed out by this author and co-authors in the fourth edition of The Tobacco Atlas, tobacco control 'involves a political and economic panoply of global social and demographic change, government policy and corporate strategies, including tobacco industry activities such as smuggling, deceptive marketing and evasion of corporate responsibility. There is a need for multilateral approaches to reducing the epidemic, requiring action by the World Health Organization, other UN agencies, governmental and non-governmental organizations (NGOs), including non-health NGOs such as environmental and women's organizations, the private sector and concerned individuals-in fact the whole of civil society'. 8 The role of governments But even in this sphere, civil society-including the health professions-has a vital role in supporting, cajoling and sometimes confronting governments into taking these actions, by research (on prevalence, consumption, disease, death, economics, tracking the tobacco industry), advocacy and lobbying, and public health education. The medical profession has a unique and authoritative role in usually being a trusted and respected profession and expert on health. The obstacles to tobacco control are surprisingly similar around the world, even among highly varied types and styles of government from kings to communists (see Table 1 )
The tools are there: there are now proven, cost-effective tools that work in all countries. International treaties, such as the Rights of the Child, the Convention on the Elimination of All Forms of Discrimination Against Women (CEDAW) and the Treaty of Rome all carry clauses pertaining to the rights to health, but the 2005 WHO's FCTC is the first attempt to utilize international law solely to further public health (see Table 2 ).
The adoption of the WHO FCTC was successful largely as a result of support from LMIC, who saw the tobacco epidemic with all its attendant economic costs looming on the horizon and who felt the need for protection from Big Tobacco. By early 2012 it had been ratified by 174 countries, 9 making it one of the fastest track UN conventions of all time. (Table 3) has been introduced to offer guidance and practical interventions to support the WHO FCTC-the two have been described as two sides of the same coin.
Monitoring the epidemic shows that in the past 2 years, .1 billion people around the world have been exposed to, and newly protected by, tobacco control interventions, including mass media campaigns, 10, 11 graphic health warnings 12, 13 and smoke-free policies. The Global Tobacco Surveillance System is now conducting global, standardized surveys on youth, adults, health professionals and school personnel. 14 The UN High-Level Summit on Non-communicable diseases (NCDs) in September 2011 is only the second UN summit on health (the previous one being on AIDS, leading to the establishment of the Global Fund to fight AIDS, tuberculosis and malaria), and offers a further opportunity to place tobacco firmly on the global health and development agenda.
It was recognized that there was an intertwining of the four major NCDs and their major causes (Table 4) , thus the need for coordination and cooperation between various agencies. In addition, the meeting called on WHO to develop a comprehensive global monitoring framework and prepare recommendations for a set of voluntary global targets for the prevention and control of NCDs, for consideration by member states in 2012-the first time such targets have been set. 15, 16 The initial global target for tobacco smoking is a '40% relative reduction in the prevalence of current daily tobacco smoking among persons 17 Others, such as the Lancet Group, have suggested 'end-game' targets of prevalence rates of under 5% by 2040. 18 Other major achievements in tobacco control include strengthening of the international non-governmental movement against tobacco; 19 research on the prevalence and attitudes of smoking among adults and youth; 20 continuing and expanded World Conferences on Tobacco or Health; financial contributions of major international donors increasing the levels of funding for tobacco control efforts in LMICs 21, 22 ; and the series of WHO Reports on the Global Tobacco Epidemic, 23 which provide an unprecedented level of detail and roadmaps for effective solutions and significant reduction in smoking prevalence rates in many parts of the world.
Failures and challenges
Regrettably, there are still many areas that need addressing. Government funding remains incommensurate with the magnitude of the problem. The current Millennium Development Goals make no specific mention of NCDs, yet are tasked to consider poverty. Other UN agencies, such as the International Labour Organization, do not have any mention of smoking with regard to the safety of the workplace. The tobacco industry is using new and more persuasive tactics to promote its image and its product, including new media, neolibertarian front groups and legal challenges to legislation. This industry will not go quietly into the sunset.
Evaluation
Evaluation of tobacco control can be complicated by the fact that often many different actions are taken simultaneously-for example, mass media counter-marketing spots on TV, a ban on advertising and sponsorship and a tax increase. But overall, success can be judged by the number of countries that have ratified and then implemented the Articles of the WHO FCTC or by reduction in prevalence rates. But the best 'ready reckoner' is what Australian colleagues cheekily named the 'scream test'. The louder the tobacco industry screams, the more effective the policy is likely to be. Thus, they are screaming very loudly at plain packaging being introduced in Australia, but taking practically no notice of health education in schools or a ban on sales to minors (neither of the latter have any effect on smoking rates; Table 5 ).
Tobacco control policies
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Lessons learned
The non-communicable disease epidemics of the 21st century challenge health professionals with a very new paradigm, which includes the use of treaties, law and litigation for public health; they emphasize the crucial role of governments, the need to address an extraordinary reach of issues, from corporate criminality to poverty alleviation, political mapping of obstacles, especially misperceived economic concerns and the tactics of vested industries and the need to set targets.
Tobacco control has moved from being perceived as quirky and individual action to mainstream public health. It has forced the health community to realize that prevention is the only way to prevent new generations of smokers/tobacco users. But if tobacco is now positioned in the mainstream of public health, it requires a framework of public health policies, including research; identification of public health objectives, and how these should be framed; identification of the key decision-makers, to whom they answer, if they can be influenced and how; identification of groups or individuals to be involved (inside and outside government); obstacles and how to overcome them; the strengths and weaknesses of the opposition; and clarifying media advocacy objectives. 24 This public health campaign outline is almost identical to Sun Tzu's 'Art of War' battle strategies in 500BC 25 to (i) measure the distances; (ii) estimate the expenses; (iii) evaluate the forces; (iv) assess the possibilities; and (v) plan for victory. Tobacco (1990) and international web-based networks on tobacco Sound research on the effects of tobacco and second-hand smoke, the economic costs of tobacco and the behaviour of the tobacco companies Comprehensive policies, including legislation and tax and price policies Enforcement after legislation Effective advocacy-this has had to be learned 'on the job' Often very little funding (but recent funding has had a significant effect) The use of the mass media Vigorous opposition from tobacco industry: although this is mostly disadvantageous, it can cause such a sense of outrage that it has the opposite effect on decision-makers Determination, persistence, realism, optimism-the key traits for a tobacco control advocate!
The future
Even if prevalence is reduced, the absolute number of smokers and the number of tobacco-related deaths are predicted to rise for several decades, largely because of the combined effects of global population increases, the population pyramid and ageing in the LMIC, and the concern remains that more girls and women might begin smoking in the LMICs. 26 Thus, the tobacco burden, in particular the strain on national economies, health systems, business and industry, the environment, the individual smoker and their families, is having increasing impact on LMIC.
High rates of tobacco use are projected to lead to a doubling of the number of tobacco-related deaths between 2010 and 2030 in LMIC (Fig. 1) . 27 Overall, in the 20th century, tobacco killed 100 million, and it is anticipated to kill 10 times that number-1 billion-in the 21st century. 28 A 2004 study by the UN Food and Agriculture Organization (FAO) predicted that developing countries would consume 71% of the world's tobacco in 2010. 29 China is the global tobacco hotspot, with .300 million smokers and 35% of the world's tobacco production. 30 The economic burden caused by death, disease and disability caused by tobacco use more than outweighs any economic benefit from their manufacture and sale.
A joint World Economic Forum and Harvard study in 2011 noted that over the next 20 years, NCDs will cost .US$ 30 trillion, representing 48% of global GDP in 2010, and pushing millions of people below the poverty line. 31 The study concluded that the future costs of inaction on tobacco far outweighed investment on prevention today, by a factor of 3. The costs of inaction will be borne mainly by the economically wealthier countries, but the middle-income countries will experience the sharpest increase in expenditure. The take-home message is that NCDs affect development and poverty.
The encouraging news is that systems are being put in place that will eventually reduce this epidemic; the WHO FCTC, WHO MPOWER policies, regional and country action plans and potentially the outcome of the UN Summit provide powerful tools, targets and guidelines for country action. Legislation and regulation (e.g. the US Family Smoking Prevention and Tobacco Control Act) are increasing at a country level in most countries in the world.
In terms of sustainability, the Bloomberg-Gates funding looks set to continue long term, but it is imperative that governments step up funding which, after all, is their core responsibility.
Conclusions
The tobacco epidemic has shown that the curative-based medical model is insufficient to reduce the use of tobacco, and that this will only be achieved by prevention and public health policy measures. The epidemics of the 21st century require a new paradigm: international law/treaties, political will, mapping of obstacles, new partners and coalitions, effective advocacy, the use of the media, comprehensive policies and enforcement, all based on sound epidemiology.
Tobacco control has come of age; it has morphed from ad hoc pockets of advocacy into mainstream public health, with a rightful place at the highest table of the UNs.
We stand at a critical juncture in the unfolding pandemic. The magnitude of the health risks and the economic factors can only lead to one conclusion: there needs to be hard-hitting, well-funded campaigns in all countries and at all levels to avert initiation, decrease consumption, assist with cessation and protect non-smokers. We must embrace the spirit of the WHO FCTC by implementing robust, effective, costeffective measures to protect people's health and the wealth of nations. We should be so bold.
